Vision Retirement’s Biogen BIIB Stock Holding History

Vision Retirement’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32K	Hold	20	–	–	﹤0.01%	524
2026 Q1	$3.67K	Hold	20	–	–	﹤0.01%	519
2025 Q4	$3.52K	Buy	+20	New	+$3.27K	﹤0.01%	515

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vision Retirement's BIIB Position: Q2 2026 in Review

Vision Retirement held its Biogen (BIIB) position steady in Q2 2026 at 20 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Vision Retirement first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 981 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Vision Retirement held 20 shares of Biogen worth $4.32K as of Q2 2026.
Vision Retirement left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Vision Retirement's portfolio in Q2 2026, its #524 holding.
Vision Retirement first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
981 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.